Human T cell glycosylation and implications on immune therapy for cancer

Hum Vaccin Immunother. 2020 Oct 2;16(10):2374-2388. doi: 10.1080/21645515.2020.1730658. Epub 2020 Mar 18.

Abstract

Glycosylation is an important post-translational modification, giving rise to a diverse and abundant repertoire of glycans on the cell surface, collectively known as the glycome. When focusing on immunity, glycans are indispensable in virtually all signaling and cell-cell interactions. More specifically, glycans have been shown to regulate key pathophysiological steps within T cell biology such as T cell development, thymocyte selection, T cell activity and signaling as well as T cell differentiation and proliferation. They are of major importance in determining the interaction of human T cells with tumor cells. In this review, we will describe the role of glycosylation of human T cells in more depth, elaborate on the importance of glycosylation in the interaction of human T cells with tumor cells and discuss the potential of cancer immunotherapies that are based on manipulating the glycome functions at the tumor immune interface. 1,2.

Keywords: Glycosylation; engineering; glycan-binding protein; human T cell; immunotherapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Glycosylation
  • Humans
  • Neoplasms* / therapy
  • Polysaccharides
  • Protein Processing, Post-Translational
  • T-Lymphocytes*

Substances

  • Polysaccharides